Jennison Associates LLC Seres Therapeutics, Inc. Transaction History

Jennison Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	BUY	$4.67 - $6.55 $3.4 Million - $4.77 Million	727,622 Added 109.46%	1,392,356 $6.67 Million
Q1 2023 Apr 26, 2023	SELL	$4.95 - $6.09 $18,349 - $22,575	-3,707 Reduced 0.55%	664,734 $3.77 Million
Q4 2022 Feb 09, 2023	BUY	$5.09 - $9.05 $3.4 Million - $6.05 Million	668,441 New	668,441 $3.74 Million
Q2 2018 Aug 02, 2018	SELL	$6.91 - $9.55 $1.45 Million - $2.01 Million	-210,198 Closed	0 $0
Q1 2018 Apr 20, 2018	SELL	$7.34 - $11.16 $127,627 - $194,050	-17,388 Reduced 7.64%	210,198 $1.54 Million

Q4 2017 Jan 25, 2018	BUY	$9.15 - $12.64 $2.08 Million - $2.88 Million	227,586	227,586 $2.31 Million

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.